Publications by authors named "Mark L Tykocinski"

Claim this Profile
A
Academic Pathology's "Spiderless Network": The power of a professional society, its listserv, and its journal during a public health emergency.
Mark L Tykocinski

Acad Pathol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virchow at 200 and Lown at 100 - Physicians as Activists.
Salvatore Mangione, Mark L Tykocinski

N Engl J Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicology and Pharmacokinetic Studies in Mice and Nonhuman Primates of the Nontoxic, Efficient, Targeted Hexameric FasL: CTLA4-FasL.
Efi Makdasi, Shira Amsili, Alexandra Aronin, Tatyana B Prigozhina, Kobi Tzdaka, Mark L Tykocinski

Mol Cancer Ther· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HuR Contributes to TRAIL Resistance by Restricting Death Receptor 4 Expression in Pancreatic Cancer Cells.
Carmella Romeo, Matthew C Weber, Mahsa Zarei, Danielle DeCicco, Saswati N Chand, Mark L Tykocinski

Mol Cancer Res· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identifying potential engaging leaders within medical education: The role of positive influence on peers.
Barret Michalec, J Jon Veloski, Mohammadreza Hojat, Mark L Tykocinski

Med Teach· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Can empathy, other personality attributes, and level of positive social influence in medical school identify potential leaders in medicine?
Mohammadreza Hojat, Barret Michalec, J Jon Veloski, Mark L Tykocinski

Acad Med· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fn14•TRAIL effectively inhibits hepatocellular carcinoma growth.
Alexandra Aronin, Shira Amsili, Tatyana B Prigozhina, Kobi Tzdaka, Jacob Rachmilewitz, Mark L Tykocinski

PLoS One· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Energy transfer in "parasitic" cancer metabolism: mitochondria are the powerhouse and Achilles' heel of tumor cells.
Ubaldo E Martinez-Outschoorn, Richard G Pestell, Anthony Howell, Mark L Tykocinski, Fnu Nagajyothi

Cell Cycle· December 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40·FasL and CTLA-4·FasL fusion proteins induce apoptosis in malignant cell lines by dual signaling.
Ariel Orbach, Jacob Rachmilewitz, Noam Shani, Yonatan Isenberg, Miriam Parnas, Mark L Tykocinski

Am J Pathol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of effector function but not T cell activation and increase in FoxP3 expression in T cells differentiated in the presence of PP14.
Zohar Ochanuna, Anat Geiger-Maor, Adi Dembinsky-Vaknin, Dimitrios Karussis, Mark L Tykocinski

PLoS One· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fn14-TRAIL, a chimeric intercellular signal exchanger, attenuates experimental autoimmune encephalomyelitis.
Marjaneh Razmara, Brendan Hilliard, Azadeh K Ziarani, Ramachandran Murali, Srikanth Yellayi, Mark L Tykocinski

Am J Pathol· February 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
Marjaneh Razmara, Brendan Hilliard, Azadeh K Ziarani, Youhai H Chen, Mark L Tykocinski

Int Immunol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer.
Yukiko Tone, Keiji Furuuchi, Yoshitsugu Kojima, Mark L Tykocinski, Mark I Greene

Nat Immunol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA-4 . FasL induces early apoptosis of activated T cells by interfering with anti-apoptotic signals.
Ariel Orbach, Jacob Rachmilewitz, Miram Parnas, Jui-Han Huang, Mark L Tykocinski

J Immunol· December 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
OX40 gene expression is up-regulated by chromatin remodeling in its promoter region containing Sp1/Sp3, YY1, and NF-kappa B binding sites.
Yukiko Tone, Yoshitsugu Kojima, Keiji Furuuchi, Maya Brady, Yumi Yashiro-Ohtani, Mark L Tykocinski

J Immunol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
alpha2,6-Sialylation promotes binding of placental protein 14 via its Ca2+-dependent lectin activity: insights into differential effects on CD45RO and CD45RA T cells.
Eliran Ish-Shalom, Ari Gargir, Sabine André, Zipora Borovsky, Zohar Ochanuna, Mark L Tykocinski

Glycobiology· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pathology as the enabler of human research.
James M Crawford, Mark L Tykocinski

Lab Invest· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pregnancy zone protein is a carrier and modulator of placental protein-14 in T-cell growth and cytokine production.
Erin L Skornicka, Nadya Kiyatkina, Matthew C Weber, Mark L Tykocinski, Peter H Koo

Cell Immunol· August 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential regulation of Th1/Th2 cytokine responses by placental protein 14.
Galit Mishan-Eisenberg, Zipora Borovsky, Matthew C Weber, Roi Gazit, Mark L Tykocinski

J Immunol· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.
Mark L Tykocinski, Aoshuang Chen, Jui-Han Huang, Matthew C Weber, Guoxing Zheng

Immunol Res· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CTLA-4. FasL induces alloantigen-specific hyporesponsiveness.
Michal Dranitzki Elhalel, Jui-Han Huang, William Schmidt, Jacob Rachmilewitz, Mark L Tykocinski

J Immunol· June 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Negative regulation of T cell activation by placental protein 14 is mediated by the tyrosine phosphatase receptor CD45.
Jacob Rachmilewitz, Zipora Borovsky, Gregory J Riely, Robin Miller, Mark L Tykocinski

J Biol Chem· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative interplay between activating and pro-apoptotic signals dictates T cell responses.
Aoshuang Chen, Guoxing Zheng, Mark L Tykocinski

Cell Immunol· February 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lipid length controls antigen entry into endosomal and nonendosomal pathways for CD1b presentation.
D Branch Moody, Volker Briken, Tan-Yun Cheng, Carme Roura-Mir, Mark R Guy, Mark L Tykocinski

Nat Immunol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Focal localization of placental protein 14 toward sites of TCR engagement.
Jacob Rachmilewitz, Zipora Borovsky, Galit Mishan-Eisenberg, Einat Yaniv, Gregory J Riely, Mark L Tykocinski

J Immunol· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis